Coagulation Profile in Patients with Thalassemia
DOI:
https://doi.org/10.21276/apalm.3641Keywords:
Thalassemia, Coagulation Profile, Hematological Parameters, Blood Transfusion, HypercoagulabilityAbstract
Background: Thalassemia is a genetic blood disorder characterized by defective hemoglobin synthesis, leading to anemia and requiring regular blood transfusions. The present study investigates coagulation profile changes in thalassemia patients and their correlation with hematological and biochemical parameters.
Methods: This is hospital-based cross-sectional type of prospective study and was conducted at JLN Hospital, Ajmer, from April 2022 to April 2024. Fifty thalassemia patients and fifty healthy controls were selected. Hematological parameters, liver function tests, coagulation markers (PT, APTT, D-Dimer, Fibrinogen), and ferritin levels were assessed. Statistical analysis was performed using SPSS software.
Result: The study revealed significant differences in Hb levels, liver enzymes (AST, ALT, ALP), coagulation parameters (PT, APTT), D-dimer and serum ferritin between thalassemia patients and controls. Thalassemia major patients exhibited more severe abnormalities than intermedia patients. No significant difference was observed in WBC count, Platelet count, Total Bilirubin, Albumin levels and Serum Fibrinogen.
Conclusion: Thalassemia patients exhibit distinct hematological and coagulation abnormalities, with implications for clinical management and transfusion strategies. Further research is needed to explore targeted interventions to mitigate these complications.
References
1. Wintrobe MM, Greer JP, Arber DA, et al. Wintrobe's Clinical Hematology. 15th ed. Wolters Kluwer; 2023.
2. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
3. Sood R, Ghosh K, Kumar M, et al. Prevalence of thalassemia in India: A systematic review. Eur J Haematol. 2022:109(1):1-11.
4. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135-46.
5. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-42.
6. Anderson GJ, McArdle HJ. Iron overload in thalassemia: Mechanisms and clinical implications. J Hepatol. 2018;68(1):104-13.
7. Cappellini MD, Robbiolo L, Bottasso BM, et al. Venous thromboembolism in splenectomized patients with thalassemia. Br J Haematol. 2000 111(2):467-73.
8. Porter J, Hassan A, Aydinok Y, et al. Deferasirox versus deferoxamine in patients with iron overload. Blood. 2011 118(22):4437-44.
9. Nathani R. Thalassemia major on the verge of bleeding or thrombosis. Br J Haematol. 2006;132(4):417-20.
10. Faraj SA. Hemostatic parameters in Thalassemia patients. J Fac Med Baghdad. 2016;58(2):132-5.
11. Eldor A. Hemorrhagic tendency in beta-thalassemia major. Isr J Med Sci. 1978;14:1132-4.
12. Fallahzadeh MH, et al. Hematuria in beta-thalassemia major. Iran J Kidney Dis. 2010;4:133-6.
13. Naithani R, et al. Thalassemia major on the verge of bleeding or thrombosis? Hematology. 2006;11:57-61.
14. Kattamis C, Giardina PJ. Coagulation abnormalities in thalassemia. Hematol Oncol Clin North Am. 2016 30(2):231-47.
15. Gamberini MR, Castriota F, Pippa L. The impact of iron overload on liver function in thalassemia patients. Hematology. 2022 27(2):98- 106.
16. Antman EM, Loscalzo J. Arterial Thrombosis. In: Harrison's Principles of Internal Medicine. 20th ed. McGraw-Hill Education; 2016:99-102.
17. Weatherall DJ, Clegg JB. The Thalassemia Syndromes. 4th ed. Oxford University Press; 2008:417-20.
18. Higgs DR, Vickers MA, Wilkie AOM, et al. A review of the molecular genetics of the human globin genes. Br J Haematol. 1993:85(3):309-17.
19. Gupta R, Arora S, Rajput A, et al. Thalassemia in India: A comprehensive review. Hemoglobin. 2020;44(3):187-94.
20. Cunningham MJ, Macklin EA, Neufeld EJ, Vichinsky EP. Management of -thalassemia. Hematology Am Soc Hematol Educ Program. 2004:13-26.
21. Lattanzi A, Pagliuca A, Ferrari G, et al. Gene therapy for beta-thalassemia: advances and challenges, Mol Ther. 2020;28(6):1281-94.
22. Musallam KM, Taher AT, Rivella S. Non-transfusion-dependent thalassemias. Haematologica. 2013;98(6):833-44.
23. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002:99(1):36-43
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nidhi Yadav, Vandana Porwal, Vandana Yadav, Kamlesh Tanwani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
